Atypical antipsychotics are a second generation of pharmaceutical interventions used to treat a range of mental health problems including schizophrenia, aggression and depression. They operate in a number of different ways, but most alter the behaviour of serotonin and dopamine receptors – a characteristic that distinguishes them from early pharmaceutical responses to acute mental ill-health.